Focused Wealth Management, Inc Tg Therapeutics, Inc. Transaction History

Focused Wealth Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 19, 2020	SELL	$18.49 - $27.24 $869 - $1,280	-47 Closed	0 $0
Q2 2020 Jul 24, 2020	SELL	$8.9 - $21.84 $445 - $1,092	-50 Reduced 51.55%	47 $1,000
Q1 2020 May 06, 2020	SELL	$7.14 - $15.99 $26,775 - $59,962	-3,750 Reduced 97.48%	97 $1,000
Q3 2019 Nov 06, 2019	BUY	$5.38 - $8.99 $20,696 - $34,584	3,847 New	3,847 $22,000

349

89.5M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.61B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.